...
首页> 外文期刊>Nanoscience and Nanotechnology Letters >Hepatic Stellate Cells Inhibit Epithelial-to-Mesenchymal Transition of Hepatoma Cells: Effect of MiR-233 Modification on Exosomes
【24h】

Hepatic Stellate Cells Inhibit Epithelial-to-Mesenchymal Transition of Hepatoma Cells: Effect of MiR-233 Modification on Exosomes

机译:肝星状细胞抑制肝癌细胞的上皮 - 间充质转变:miR-233改性对外来的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatic stellate cells (HSCs) dominate the malignant microenvironment that induces metastasis related epithelial-to-mesenchymal transition (EMT) of hepatocellular carcinoma (HCC). Here, we employed miR-223 to modify the activated HSCs. HSC-secreted exosomes were integrated to hepatoma cells (HepG2 and Huh7). Dramatic increase in exosomal miR-223, and then intracellular miR-223 in both types of cells revealed the transcellular delivery of miRNA. The miR-223-specific inhibitory effect on Sp1 abolished mesenchymal markers (N-cadherin, Vimentin), and rescued epithelial marker of E-cadherin. Wound healing and transwell assay exhibited the amelioration of invasion in hepatoma cells. These findings highlight the exosome-mediated regulation of miRNA by HSCs modification, which renders a potential therapy for HCC based on EMT attenuation.
机译:肝星状细胞(HSCs)占据恶性微环境,诱导肝细胞癌(HCC)的转移相关的上皮 - 间充质转换(EMT)。 在这里,我们使用MIR-223来修改激活的HSC。 将HSC分泌的外泌体整合到肝癌细胞(Hepg2和Huh7)中。 外泌体miR-223的显着增加,然后两种细胞中的细胞内miR-223揭示了miRNA的介性递送。 对SP1的miR-223特异性抑制作用废除间充质标记物(n-cadherin,Vimentin)和救出的E-cadherin上皮标记物。 伤口愈合和Transwell测定表现出肝癌细胞侵袭的改善。 这些发现突出了HSCS改性的外鼻孔介导的miRNA调节,这使得基于EMT衰减的HCC潜在疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号